Stockreport

Independent Director of Design Therapeutics Picks Up 88% More Stock [Yahoo! Finance]

Design Therapeutics, Inc.  (DSGN) 
PDF NASDAQ:DSGN ) Independent Director, John Schmid, recently bought US$100k worth of stock, for US$3.70 per share. Even though that isn't a massive buy, it did increase the [Read more]